InflaRx (IFRX) CFO details extensive stock option and share holdings

Rhea-AI Filing Summary

InflaRx N.V. Chief Financial Officer Thomas Taapken has filed an initial Form 3 detailing his equity holdings in the company. The filing shows indirect ownership, through tomtaa GmbH, of multiple stock option grants over Ordinary Shares with exercise prices generally around 1.86–2.44 and staggered expirations from 2030 to 2036. One grant covers 240,000 options expiring in 2036 and another 210,000 expiring in 2034. A separate performance stock option for 72,000 shares vests based on a financing event and the average Ordinary Share price in quarter four of 2026 exceeding $1.50. Taapken also directly holds 3,500 Ordinary Shares. Several option grants are already fully vested and exercisable, while the January 2026 grant vests in four equal quarterly installments, all subject to continued service.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Taapken Thomas

(Last) (First) (Middle)

C/O INFLARX N.V.

WINZERLAER STREET 2

(Street)

JENA 07745

(City) (State) (Zip)

GERMANY

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
InflaRx N.V. [ IFRX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	3,500	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	09/17/2030	Ordinary Shares	150,000	$1.86	I	By tomtaa GmbH(2)
Stock Option (Right to Buy)	(3)	01/04/2031	Ordinary Shares	50,000	$1.86	I	By tomtaa GmbH(2)
Stock Option (Right to Buy)	(4)	07/01/2031	Ordinary Shares	32,002	$1.86	I	By tomtaa GmbH(2)
Stock Option (Right to Buy)	(5)	01/11/2032	Ordinary Shares	110,000	$1.86	I	By tomtaa GmbH(2)
Stock Option (Right to Buy)	(6)	11/21/2032	Ordinary Shares	55,000	$2.44	I	By tomtaa GmbH(2)
Stock Option (Right to Buy)	(7)	01/24/2033	Ordinary Shares	110,000	$2.37	I	By tomtaa GmbH(2)
Stock Option (Right to Buy)	(8)	01/05/2034	Ordinary Shares	210,000	$1.79	I	By tomtaa GmbH(2)
Stock Option (Right to Buy)	(9)	01/03/2035	Ordinary Shares	240,000	$2.41	I	By tomtaa GmbH(2)
Stock Option (Right to Buy)	(10)	01/06/2036	Ordinary Shares	240,000	$1.17	I	By tomtaa GmbH(2)
Performance Stock Option (Right to Buy)	(11)	01/06/2036	Ordinary Shares	72,000	$1.17	I	By tomtaa GmbH(2)

Explanation of Responses:

1. This option was granted on September 18, 2020 and is fully vested and exercisable as of the date hereof.

2. The reported securities are directly held by tomtaa GmbH, a company wholly owned by the Reporting Person for which the Reporting Person acts as sole managing director. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.

3. This option was granted on January 4, 2021 and is fully vested and exercisable as of the date hereof.

4. This option was granted on July 2, 2021 and is fully vested and exercisable as of the date hereof.

5. This option was granted on January 12, 2022 and is fully vested and exercisable as of the date hereof.

6. This option was granted on November 21, 2022 and is fully vested and exercisable as of the date hereof.

7. This option was granted on January 24, 2023 and is fully vested and exercisable as of the date hereof.

8. This option was granted on January 5, 2024 and is fully vested and exercisable as of the date hereof.

9. This option was granted on January 3, 2025 and is fully vested and exercisable as of the date hereof.

10. This option was granted on January 6, 2026 and will vest and become exercisable in four equal installments of 60,000 shares on each quarterly anniversary of such grant date, subject to continued service through such dates.

11. This option shall vest depending upon achievement of the following performance criteria: (i) 50% shall vest if a certain financing event takes place before the fourth quarter of 2026 and (ii) 50% shall vest if the average Ordinary Share price for quarter four of 2026 exceeds $1.50.

Remarks:

Exhibit List - Exhibit 24.1 Power of Attorney

	/s/ Christian Schmid, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)